Skip to main content
VCbacked
Log inGet Started

Dice Therapeutics

San Francisco, United States

Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.

$345.0M raised
Oct 2022
Post-IPO Equity
BiotechnologyMedicalMedical Device

Top Investors

RA Capital ManagementSands Capital VenturesJanus Henderson InvestorsOUP (Osage University Partners)Sanofi Ventures

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Dice Therapeutics

How much funding has Dice Therapeutics raised?
Dice Therapeutics has raised $345.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2022.
Who are Dice Therapeutics's investors?
Dice Therapeutics's investors include RA Capital Management, Sands Capital Ventures, Janus Henderson Investors, OUP (Osage University Partners), Sanofi Ventures.
Where is Dice Therapeutics headquartered?
Dice Therapeutics is headquartered in San Francisco, United States.
What does Dice Therapeutics do?
Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.
What stage is Dice Therapeutics at?
Dice Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Dice Therapeutics — Funding & Investors." VCBacked, October 17, 2022, https://www.vcbacked.co/company/dice-therapeutics. Accessed July 5, 2026.
APA
VCBacked. (2022). Dice Therapeutics — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/dice-therapeutics
Wikipedia (cite web)
{{cite web |title=Dice Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/dice-therapeutics |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K